Home
Giới thiệu
Tài khoản
Đăng nhập
Quên mật khẩu
Đổi mật khẩu
Đăng ký tạo tài khoản
Liệt kê
Công trình khoa học
Bài báo trong nước
Bài báo quốc tế
Sách và giáo trình
Thống kê
Công trình khoa học
Bài báo khoa học
Sách và giáo trình
Giáo sư
Phó giáo sư
Tiến sĩ
Thạc sĩ
Lĩnh vực nghiên cứu
Tìm kiếm
Cá nhân
Nội dung
Góp ý
Hiệu chỉnh lý lịch
Thông tin chung
English
Đề tài NC khoa học
Bài báo, báo cáo khoa học
Hướng dẫn Sau đại học
Sách và giáo trình
Các học phần và môn giảng dạy
Giải thưởng khoa học, Phát minh, sáng chế
Khen thưởng
Thông tin khác
Tài liệu tham khảo
Hiệu chỉnh
Số người truy cập: 106,838,936
Cost Effectiveness Analysis and Payment Policy Recommendation—Population-Based Survey with Big Data Methodology for Readmission Prevention of Patients with Paroxysmal Supraventricular Tachycardia treated with Radiofrequency Catheter Ablation
Tác giả hoặc Nhóm tác giả:
Chien-Lung Chan, Ai-Hsien Adams Li, Hsiang-An Chung, Dinh-Van Phan
Nơi đăng:
International Journal of Environmental Research and Public Health (SCIE);
S
ố:
17(7);
Từ->đến trang
: 2334;
Năm:
2020
Lĩnh vực:
Y - Dược;
Loại:
Bài báo khoa học;
Thể loại:
Quốc tế
TÓM TẮT
Recurrence of paroxysmal supraventricular tachycardia (PSVT) has been reported to be lower in patients treated with radiofrequency catheter ablation (RFCA) than in those who are not. Few population-based surveys have stated the cost-effectiveness related to this treatment. We, therefore, performed a nationwide retrospective study using National Health Insurance Research Database (NHIRD) data from 2001–2012 in Taiwan. The incidence of PSVT-related admissions was computed from patients’ first admission for a primary PSVT diagnosis. There were 21,086 patients hospitalized due to first-time PSVT, of whom 13,075 underwent RFCA, with 374 recurrences (2.86%). In contrast, 1751 (21.86%) of the remaining 8011 patients who did not receive RFCA, most of whom had financial concerns, experienced PSVT recurrence. The relative PSVT recurrence risk in those who did not receive RFCA was 7.6 times (95% CI: 6.67–8.33) that of those who did undergo RFCA. In conclusion, the PSVT recurrence rate was much higher in patients who did not receive RFCA at their first admission. Furthermore, RFCA proved cost-effective, with the ratio of the incremental cost-effectiveness ratio (ICER) and gross domestic product (GDP) being only 1.15. To prevent readmission and avoid incremental cost, the authority could provide a financial supplement for every patient so that the procedure is performed, reducing the PSVT-recurrence life-years (disease-specific DALY).
ABSTRACT
Recurrence of paroxysmal supraventricular tachycardia (PSVT) has been reported to be lower in patients treated with radiofrequency catheter ablation (RFCA) than in those who are not. Few population-based surveys have stated the cost-effectiveness related to this treatment. We, therefore, performed a nationwide retrospective study using National Health Insurance Research Database (NHIRD) data from 2001–2012 in Taiwan. The incidence of PSVT-related admissions was computed from patients’ first admission for a primary PSVT diagnosis. There were 21,086 patients hospitalized due to first-time PSVT, of whom 13,075 underwent RFCA, with 374 recurrences (2.86%). In contrast, 1751 (21.86%) of the remaining 8011 patients who did not receive RFCA, most of whom had financial concerns, experienced PSVT recurrence. The relative PSVT recurrence risk in those who did not receive RFCA was 7.6 times (95% CI: 6.67–8.33) that of those who did undergo RFCA. In conclusion, the PSVT recurrence rate was much higher in patients who did not receive RFCA at their first admission. Furthermore, RFCA proved cost-effective, with the ratio of the incremental cost-effectiveness ratio (ICER) and gross domestic product (GDP) being only 1.15. To prevent readmission and avoid incremental cost, the authority could provide a financial supplement for every patient so that the procedure is performed, reducing the PSVT-recurrence life-years (disease-specific DALY).
© Đại học Đà Nẵng
Địa chỉ: 41 Lê Duẩn Thành phố Đà Nẵng
Điện thoại: (84) 0236 3822 041 ; Email: dhdn@ac.udn.vn